Literature DB >> 22089925

Regulation of rat MOR-1 gene expression after chronic intracerebroventricular administration of morphine.

Zhi-Ping Zhu1, Ramesh B Badisa, Donald E Palm, Carl B Goodman.   

Abstract

The µ-opioid receptor is the primary site for the action of morphine. In the present study, we investigated the regulation of the µ-opioid receptor mRNA levels in the locus ceruleus, ventral tegmental area, nucleus accumbens and hypothalamus of the rat brain following intracerebroventricular administration of morphine for 7 days. The isolated mRNA from these regions was subjected to real-time quantitative RT-PCR to determine the regulation of µ-opioid receptor gene expression. It was observed that 7 days of treatment with morphine significantly down-regulated the µ-opioid receptor mRNA levels in the hypothalamus of the brain in comparison to the control group. However, the µ-opioid receptor levels in the locus ceruleus, ventral tegmental area and nucleus accumbens regions remained the same as the control levels. Down-regulation of µ-opioid receptor mRNA levels in the hypothalamus region of the brain indicates the probable role of opioids to influence neuroendocrine function. The results further indicate that cellular adaptation for morphine tolerance is tissue-specific. These findings help us to understand the mechanism of morphine tolerance in various regions of the brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22089925      PMCID: PMC3320148          DOI: 10.3892/mmr.2011.677

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  21 in total

1.  A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors.

Authors:  Michael Tanowitz; Mark von Zastrow
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

Review 2.  Structure and regulation of opioid receptors.

Authors:  K Chaturvedi; K H Christoffers; K Singh; R D Howells
Journal:  Biopolymers       Date:  2000       Impact factor: 2.505

Review 3.  Molecular characterization of opioid receptors.

Authors:  H H Loh; A P Smith
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

4.  Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors.

Authors:  N A Sharif; J Hughes
Journal:  Peptides       Date:  1989 May-Jun       Impact factor: 3.750

5.  Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.

Authors:  H N Bhargava; A Gulati
Journal:  Eur J Pharmacol       Date:  1990-11-13       Impact factor: 4.432

6.  Decrease in mu-opioid receptor binding capacity in rat brain after chronic PL017 treatment.

Authors:  P L Tao; H Y Lee; L R Chang; H H Loh
Journal:  Brain Res       Date:  1990-09-03       Impact factor: 3.252

7.  Chronic morphine increases mu-opiate receptor binding in rat brain: a quantitative autoradiographic study.

Authors:  L S Brady; M Herkenham; J B Long; R B Rothman
Journal:  Brain Res       Date:  1989-01-16       Impact factor: 3.252

8.  FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat.

Authors:  D H Malin; J R Lake; D E Fowler; M V Hammond; S L Brown; J E Leyva; P E Prasco; T M Dougherty
Journal:  Peptides       Date:  1990 Mar-Apr       Impact factor: 3.750

9.  Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.

Authors:  Jianren Mao; Backil Sung; Ru-Rong Ji; Grewo Lim
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

10.  Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells.

Authors:  M T Oliveira; A C Rego; M T Morgadinho; T R A Macedo; C R Oliveira
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

View more
  7 in total

1.  Spinal CX3CL1/CX3CR1 May Not Directly Participate in the Development of Morphine Tolerance in Rats.

Authors:  Yawen Peng; Genhua Guo; Bin Shu; Daiqiang Liu; Peng Su; Xuming Zhang; Feng Gao
Journal:  Neurochem Res       Date:  2017-08-03       Impact factor: 3.996

2.  Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells.

Authors:  Francesca Felicia Caputi; Francesca Lattanzio; Donatella Carretta; Daniela Mercatelli; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2013-05-29       Impact factor: 3.444

3.  Regulation of an Opioid Receptor Chaperone Protein, RTP4, by Morphine.

Authors:  Wakako Fujita; Mini Yokote; Ivone Gomes; Achla Gupta; Hiroshi Ueda; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2018-10-22       Impact factor: 4.436

4.  Regulation of mammalian MOR-1 gene expression after chronic treatment with morphine.

Authors:  Rose V Prenus; Ebens Luscar; Zhi-Ping Zhu; Ramesh B Badisa; Carl B Goodman
Journal:  Int J Mol Med       Date:  2012-09-19       Impact factor: 4.101

5.  Gene Expression Profile of Calcium/Calmodulin-Dependent Protein Kinase IIα in Rat's Hippocampus during Morphine Withdrawal.

Authors:  Shamseddin Ahmadi; Shahin Amiri; Fatemeh Rafieenia; Jalal Rostamzadeh
Journal:  Basic Clin Neurosci       Date:  2013

6.  Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells.

Authors:  R Chavez-Valdez; L Kovell; R Ahlawat; G L McLemore; M Wills-Karp; E B Gauda
Journal:  J Perinatol       Date:  2012-10-04       Impact factor: 2.521

7.  Chronic morphine regulates TRPM8 channels via MOR-PKCβ signaling.

Authors:  Mircea Iftinca; Lilian Basso; Robyn Flynn; Charlie Kwok; Corinne Roland; Ahmed Hassan; Manon Defaye; Rithwik Ramachandran; Tuan Trang; Christophe Altier
Journal:  Mol Brain       Date:  2020-04-14       Impact factor: 4.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.